Correction of an important typographical error in the European Association of Nuclear Medicine (EANM) guidelines.
作者信息
Anderson E A
出版信息
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1080. doi: 10.1007/s00259-012-2066-3.
PMID:22302091
Abstract
摘要
相似文献
1
Correction of an important typographical error in the European Association of Nuclear Medicine (EANM) guidelines.欧洲核医学协会（EANM）指南中一处重要排版错误的更正。
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1080. doi: 10.1007/s00259-012-2066-3.
2
3
The European Association of Nuclear Medicine (EANM)'s Response to the 2023 European Thyroid Association (ETA) clinical practice guidelines for thyroid nodule management and nuclear medicine: a deliberate oversight?欧洲核医学协会（EANM）对2023年欧洲甲状腺协会（ETA）甲状腺结节管理与核医学临床实践指南的回应：是有意疏忽吗？
Eur J Nucl Med Mol Imaging. 2024 May;51(6):1678-1681. doi: 10.1007/s00259-023-06571-z.
4
5
Guidelines for 131I-meta-iodobenzylguanidine therapy.
Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):BP23-6. doi: 10.1007/s00259-002-1061-5.
6
EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy.欧洲核医学协会131I-间碘苄胍（131I-mIBG）治疗程序指南
Eur J Nucl Med Mol Imaging. 2008 May;35(5):1039-47. doi: 10.1007/s00259-008-0715-3.
7
The EANM practice guidelines for bone scintigraphy.欧洲核医学与分子影像学会骨闪烁扫描实践指南。
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1723-38. doi: 10.1007/s00259-016-3415-4. Epub 2016 Jun 4.
8
The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children.SNMMI和EANM婴幼儿利尿肾图检查程序指南。
J Nucl Med. 2018 Oct;59(10):1636-1640. doi: 10.2967/jnumed.118.215921.
9
Guidelines for the use of 18F-FDG in infection and inflammation: a new step in cooperation between the EANM and SNMMI.18F-FDG在感染与炎症中的应用指南：欧洲核医学与分子影像学会（EANM）与美国核医学与分子影像学会（SNMMI）合作的新进展
Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1120-1. doi: 10.1007/s00259-013-2380-4.
10
Comparison of the EANM and SNM guidelines on diuretic renography in children.欧洲核医学与分子影像学会（EANM）与核医学学会（SNM）儿童利尿肾图指南比较
Nucl Med Commun. 2015 May;36(5):486-8. doi: 10.1097/MNM.0000000000000278.
本文引用的文献
1
EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy.欧洲核医学协会131I-间碘苄胍（131I-mIBG）治疗程序指南
Eur J Nucl Med Mol Imaging. 2008 May;35(5):1039-47. doi: 10.1007/s00259-008-0715-3.
2
High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma.神经母细胞瘤患儿在（131）I-间碘苄胍治疗期间尽管使用碘化钾进行预防，但甲状腺功能障碍的发生率仍很高。
Cancer. 2002 Apr 1;94(7):2081-9. doi: 10.1002/cncr.10447.
Zotero 插件